U.S. markets closed
  • S&P Futures

    4,200.50
    -22.50 (-0.53%)
     
  • Dow Futures

    33,857.00
    -160.00 (-0.47%)
     
  • Nasdaq Futures

    13,876.00
    -105.25 (-0.75%)
     
  • Russell 2000 Futures

    2,292.60
    -17.50 (-0.76%)
     
  • Crude Oil

    71.54
    -0.61 (-0.85%)
     
  • Gold

    1,817.50
    -43.90 (-2.36%)
     
  • Silver

    27.24
    -0.57 (-2.06%)
     
  • EUR/USD

    1.1993
    -0.0007 (-0.06%)
     
  • 10-Yr Bond

    1.5690
    +0.0700 (+4.67%)
     
  • Vix

    18.15
    +1.13 (+6.64%)
     
  • GBP/USD

    1.3983
    -0.0003 (-0.02%)
     
  • USD/JPY

    110.7070
    +0.0940 (+0.08%)
     
  • BTC-USD

    38,590.53
    -1,464.41 (-3.66%)
     
  • CMC Crypto 200

    957.30
    -35.17 (-3.54%)
     
  • FTSE 100

    7,184.95
    +12.47 (+0.17%)
     
  • Nikkei 225

    29,021.35
    -269.66 (-0.92%)
     

Should You Worry About This Threat to Moderna's Vaccine?

·4 min read
Should You Worry About This Threat to Moderna's Vaccine?
  • Oops!
    Something went wrong.
    Please try again later.

Moderna's (NASDAQ: MRNA) success story is all about its coronavirus vaccine. This is big -- especially considering Moderna didn't have any commercialized products until regulators authorized the vaccine in late December. Investors are hoping this is just the beginning of Moderna's coronavirus vaccine revenue growth.